Alanine 4.22 mg/ML / arginine 4.32 mg/ML / aspartate 2.98 mg/ML / glucose 100 mg/ML / glutamate 3.14 mg/ML / glycine 2.12 mg/ML / histidine 1.28 mg/ML / isoleucine 2.8 mg/ML / leucine 4.25 mg/ML / lysine 4.46 mg/ML / magnesium chloride 0.00148 MEQ/ML / methionine 0.73 mg/ML / phenylalanine 1.26 mg/ML / potassium chloride 0.013 MEQ/ML / proline 3.07 mg/ML / serine 2.25 mg/ML / sodium chloride 0.0205 MEQ/ML / sodium phosphate 0.00347 MEQ/ML / threonine 1.7 mg/ML / tryptophan 0.85 mg/ML / tyrosine 1.15 mg/ML / valine 2.12 mg/ML Injectable Solution [Aminosyn II 4.5 % M in 10 % Dextrose]
RxNorm 833104
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 833104 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: alanine 4.22 mg/ML / arginine 4.32 mg/ML / aspartate 2.98 mg/ML / glucose 100 mg/ML / glutamate 3.14 mg/ML / glycine 2.12 mg/ML / histidine 1.28 mg/ML / isoleucine 2.8 mg/ML / leucine 4.25 mg/ML / lysine 4.46 mg/ML / magnesium chloride 0.00148 MEQ/ML / methionine 0.73 mg/ML / phenylalanine 1.26 mg/ML / potassium chloride 0.013 MEQ/ML / proline 3.07 mg/ML / serine 2.25 mg/ML / sodium chloride 0.0205 MEQ/ML / sodium phosphate 0.00347 MEQ/ML / threonine 1.7 mg/ML / tryptophan 0.85 mg/ML / tyrosine 1.15 mg/ML / valine 2.12 mg/ML Injectable Solution [Aminosyn II 4.5 % M in 10 % Dextrose].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
